Why do people die of anaphylaxis? - A clinical review

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Anaphylaxis is a source of anxiety for patients and healthcare providers. It is a medical emergency that presents with a broad array of symptoms and signs, many of which can be deceptively similar to other diseases such as myocardial infarction, asthma, or panic attacks. In addition to these diagnostic challenges, anaphylaxis presents management difficulties due to rapid onset and progression, lack of appropriate self-treatment education and implementation by patients, severity of the allergic response, exacerbating medications or concurrent disease, and unpredictability. The most common causes of anaphylaxis are food allergies, stinging insects and immunotherapy (allergy shots) but idiopathic anaphylaxis, latex allergy and drug hypersensitive all contribute to the epidemiology. Reactions to IVP and other dyes are coined anaphylactoid reactions but have identical pathophysiology and treatment, once the mast cell has been degranulated. As many antigens can be the trigger for fatal anaphylaxis, it is useful to examine the features of each etiology individually, highlighting factors common to all fatal anaphylaxis and some specific to certain etiologies. Generally what distinguishes a fatal from non fatal reaction is often just the rapidity to apply correct therapy. Prevention is clearly the key and should identify high-risk patients in an attempt to minimize the likely of a severe reaction. Although fatal anaphylaxis is rare, it is likely underreported.

Original languageEnglish (US)
Pages (from-to)281-287
Number of pages7
JournalClinical and Developmental Immunology
Volume12
Issue number4
DOIs
StatePublished - Dec 2005

Fingerprint

Anaphylaxis
Latex Hypersensitivity
Food Hypersensitivity
Panic Disorder
Patient Education
Mast Cells
Health Personnel
Immunotherapy
Signs and Symptoms
Insects
Hypersensitivity
Epidemiology
Emergencies
Coloring Agents
Therapeutics
Asthma
Anxiety
Myocardial Infarction
Antigens
Pharmaceutical Preparations

Keywords

  • Allergy shots
  • Food allergy
  • Immunotherapy
  • Latex
  • Stinging insects

ASJC Scopus subject areas

  • Immunology
  • Cell Biology
  • Developmental Biology

Cite this

Why do people die of anaphylaxis? - A clinical review. / Kumar, Arvind; Teuber, Suzanne S; Gershwin, M. Eric.

In: Clinical and Developmental Immunology, Vol. 12, No. 4, 12.2005, p. 281-287.

Research output: Contribution to journalArticle

@article{78464c7266894b7f9e239a7e7be51c61,
title = "Why do people die of anaphylaxis? - A clinical review",
abstract = "Anaphylaxis is a source of anxiety for patients and healthcare providers. It is a medical emergency that presents with a broad array of symptoms and signs, many of which can be deceptively similar to other diseases such as myocardial infarction, asthma, or panic attacks. In addition to these diagnostic challenges, anaphylaxis presents management difficulties due to rapid onset and progression, lack of appropriate self-treatment education and implementation by patients, severity of the allergic response, exacerbating medications or concurrent disease, and unpredictability. The most common causes of anaphylaxis are food allergies, stinging insects and immunotherapy (allergy shots) but idiopathic anaphylaxis, latex allergy and drug hypersensitive all contribute to the epidemiology. Reactions to IVP and other dyes are coined anaphylactoid reactions but have identical pathophysiology and treatment, once the mast cell has been degranulated. As many antigens can be the trigger for fatal anaphylaxis, it is useful to examine the features of each etiology individually, highlighting factors common to all fatal anaphylaxis and some specific to certain etiologies. Generally what distinguishes a fatal from non fatal reaction is often just the rapidity to apply correct therapy. Prevention is clearly the key and should identify high-risk patients in an attempt to minimize the likely of a severe reaction. Although fatal anaphylaxis is rare, it is likely underreported.",
keywords = "Allergy shots, Food allergy, Immunotherapy, Latex, Stinging insects",
author = "Arvind Kumar and Teuber, {Suzanne S} and Gershwin, {M. Eric}",
year = "2005",
month = "12",
doi = "10.1080/17402520500376277",
language = "English (US)",
volume = "12",
pages = "281--287",
journal = "Journal of Immunology Research",
issn = "2314-8861",
publisher = "Hindawi Publishing Corporation",
number = "4",

}

TY - JOUR

T1 - Why do people die of anaphylaxis? - A clinical review

AU - Kumar, Arvind

AU - Teuber, Suzanne S

AU - Gershwin, M. Eric

PY - 2005/12

Y1 - 2005/12

N2 - Anaphylaxis is a source of anxiety for patients and healthcare providers. It is a medical emergency that presents with a broad array of symptoms and signs, many of which can be deceptively similar to other diseases such as myocardial infarction, asthma, or panic attacks. In addition to these diagnostic challenges, anaphylaxis presents management difficulties due to rapid onset and progression, lack of appropriate self-treatment education and implementation by patients, severity of the allergic response, exacerbating medications or concurrent disease, and unpredictability. The most common causes of anaphylaxis are food allergies, stinging insects and immunotherapy (allergy shots) but idiopathic anaphylaxis, latex allergy and drug hypersensitive all contribute to the epidemiology. Reactions to IVP and other dyes are coined anaphylactoid reactions but have identical pathophysiology and treatment, once the mast cell has been degranulated. As many antigens can be the trigger for fatal anaphylaxis, it is useful to examine the features of each etiology individually, highlighting factors common to all fatal anaphylaxis and some specific to certain etiologies. Generally what distinguishes a fatal from non fatal reaction is often just the rapidity to apply correct therapy. Prevention is clearly the key and should identify high-risk patients in an attempt to minimize the likely of a severe reaction. Although fatal anaphylaxis is rare, it is likely underreported.

AB - Anaphylaxis is a source of anxiety for patients and healthcare providers. It is a medical emergency that presents with a broad array of symptoms and signs, many of which can be deceptively similar to other diseases such as myocardial infarction, asthma, or panic attacks. In addition to these diagnostic challenges, anaphylaxis presents management difficulties due to rapid onset and progression, lack of appropriate self-treatment education and implementation by patients, severity of the allergic response, exacerbating medications or concurrent disease, and unpredictability. The most common causes of anaphylaxis are food allergies, stinging insects and immunotherapy (allergy shots) but idiopathic anaphylaxis, latex allergy and drug hypersensitive all contribute to the epidemiology. Reactions to IVP and other dyes are coined anaphylactoid reactions but have identical pathophysiology and treatment, once the mast cell has been degranulated. As many antigens can be the trigger for fatal anaphylaxis, it is useful to examine the features of each etiology individually, highlighting factors common to all fatal anaphylaxis and some specific to certain etiologies. Generally what distinguishes a fatal from non fatal reaction is often just the rapidity to apply correct therapy. Prevention is clearly the key and should identify high-risk patients in an attempt to minimize the likely of a severe reaction. Although fatal anaphylaxis is rare, it is likely underreported.

KW - Allergy shots

KW - Food allergy

KW - Immunotherapy

KW - Latex

KW - Stinging insects

UR - http://www.scopus.com/inward/record.url?scp=30344457308&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=30344457308&partnerID=8YFLogxK

U2 - 10.1080/17402520500376277

DO - 10.1080/17402520500376277

M3 - Article

C2 - 16584114

AN - SCOPUS:30344457308

VL - 12

SP - 281

EP - 287

JO - Journal of Immunology Research

JF - Journal of Immunology Research

SN - 2314-8861

IS - 4

ER -